OTCMKTS:DTCFF

Defence Therapeutics (DTCFF) Stock Price, News & Analysis

$0.96
-0.09 (-8.55%)
(As of 04/22/2024 ET)
Today's Range
$0.96
$0.96
50-Day Range
$0.96
$1.49
52-Week Range
$0.96
$3.19
Volume
500 shs
Average Volume
417 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
DTCFF stock logo

About Defence Therapeutics Stock (OTCMKTS:DTCFF)

Defence Therapeutics Inc. engages in development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on development of vaccine for infectious disease and virus utilizing the ACCUMTM platform for drug delivery and effective treatments. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

DTCFF Stock Price History

DTCFF Stock News Headlines

One trade. One ticker. One week.
Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week?
Defence Therapeutics Completes 1st Tranche of Financing
Defence Financing
Defence Therapeutics Inc DTCFF
One trade. One ticker. One week.
Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week?
Defence Therapeutics Inc (DTC)
See More Headlines
Receive DTCFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Defence Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:DTCFF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Sebastien Plouffe (Age 52)
    CEO, President & Director
    Comp: $81.52k
  • Mr. Patrick Joseph Meagher C.A. (Age 38)
    CPA, CA, CPA, CFO & Director
    Comp: $57.6k
  • Dr. Moutih Rafei Ph.D. (Age 42)
    Chief Scientific Officer & Director
    Comp: $9.06k
  • Dr. Simon Beaudoin (Age 39)
    Chief Technical Science Officer
  • Ms. Carrie Cesarone (Age 59)
    Corporate Secretary

DTCFF Stock Analysis - Frequently Asked Questions

How have DTCFF shares performed in 2024?

Defence Therapeutics' stock was trading at $1.65 at the beginning of the year. Since then, DTCFF stock has decreased by 41.7% and is now trading at $0.9623.
View the best growth stocks for 2024 here
.

How do I buy shares of Defence Therapeutics?

Shares of DTCFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:DTCFF) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners